久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

您現(xiàn)在的位置: > Language Tips > Audio & Video > Special Speed News  
 





  Once-daily pill could simplify HIV treatment
[ 2006-02-06 15:57 ]


I’m Steve Ember with the VOA Special English Health Report.


Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill
Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS, for example, are all treated with combinations of drugs.

But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day.

Now, two companies say they have done that for people just starting treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences.

They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name Sustiva. Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four.

Combining drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of H.I.V.

In January the New England Journal of Medicine published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with fewer side effects.

Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.

GlaxoSmithKline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.

The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries.

They plan in the next few months to ask the United States Food and Drug Administration to approve the new pill.

There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders.

Experts say more than forty million people around the world are living with H.I.V.

This VOA Special English Health Report was written by Cynthia Kirk. Read and listen to our reports at voaspecialenglish.com. I’m Steve Ember.

Vocabulary

 

 

 
 
 




主站蜘蛛池模板: 中文在线亚洲 | 日韩毛片免费视频一级特黄 | 美女黄色一级毛片 | 成年人在线免费网站 | 成人免费观看国产高清 | 最近中文字幕精彩视频 | 亚洲精品欧美精品国产精品 | 亚洲一区二区影院 | 日韩一区二区视频在线观看 | 一区二区三区国模大胆 | 中文字幕在线视频观看 | 欧美精品人爱c欧美精品 | 狠狠88综合久久久久综合网 | 精品无码久久久久国产 | 成人午夜在线观看 | 私人午夜影院 | 国产在线视频专区 | 国产高清在线精品一区二区三区 | 亚洲最新网址 | 欧美日韩一区二区三区在线观看 | 蕾丝视频永久在线入口香蕉 | 热热涩热热狠狠色香蕉综合 | 欧美亚洲视频 | 91香焦国产线观看看免费 | 免费观看欧美成人禁片 | 欧美性色欧美a在线播放 | 国产三级中文字幕 | 波多野结衣在线观看一区二区三区 | 色吊丝在线观看国产 | 一级毛片不卡 | 在线播放亚洲精品 | 日本三级日产三级国产三级 | 欧美日韩久久 | 在线视频日韩 | 在线观看精品国内福利视频 | 美国三级| 纯欧美一级毛片免费 | av毛片在线看 | 男女午夜免费视频 | 天堂素人搭讪系列嫩模在线观看 | 一级毛片免费不卡夜夜欢 |